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Introduction
Poor adherence to prescribed therapy is a growing con-
cern which undermines the benefits of  current medi-
cal care1-3. On an average, one-third to one-half  of  the 
patients for whom appropriate therapies are prescribed 
do not receive the full benefit from the prescribed ther-
apeutic regimen because of  inadequate adherence4-6. 
Non-adherence is especially high among patients with 
chronic diseases (including diabetes mellitus) that typi-
cally require long-term and sometimes complex treat-
ment regimen to control symptoms and prevent compli-
cations, with adherence rate dropping most dramatically 
after the first six months of  therapy2,7. 
Type 2 diabetes is a chronic disorder with increasing 
global pandemic and socio-economic burden8-10. The 
changes in lifestyle as a result of  urbanization and west-
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increase in the prevalence of  type 2 diabetes worldwide9-
11. The multiple variables to be considered in diabetes 
management typically increase the complexity of  ad-
herence enhancement and this has affected the health-
care outcome among patients12. In addition to taking 
the prescribed medications (insulin and/or oral medica-
tions) regularly and appropriately on a daily basis with 
minimal or no supervision, patients are also required to 
adhere strictly to recommended diet and exercise plans, 
as well as regularly monitoring and keeping a record of  
their own blood glucose measurements13,14. Overall, it is 
estimated that only 7% of  patients with diabetes were 
adherent with all aspects of  their treatment plans15-17. 
Poor adherence to treatment recommendations among 
diabetes patients typically results in suboptimal glyc-
emic control. However, poor glycemic control has been 
found to be associated with increasing risk of  micro- 
and macro-vascular complications, disease progres-
sion, morbidity and mortality with increasing costs of  
care18,19. Studies have identified varying number of  rea-
sons for non-adherence including forgetfulness, dose 
omission, costs and side effect of  medication, as well as 
perceived lack of  benefit from continued treatment 20,21. 
Nonetheless, there exist many challenges in further un-
derstanding the pattern of  non-adherence to treatment 
recommendations among patients with type 2 diabetes, 
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especially in developing countries where the preponder-
ance of  economic instability, low literacy level, and re-
stricted access to healthcare facilities might have led to 
increasing incidence of  non-adherence among patients 
who usually make out-of-pocket payments for their 
treatment. 
This study therefore aimed at evaluating the pattern of  
treatment non-adherence among patients with poorly 
controlled type 2 diabetes in ambulatory care settings 
in southwestern Nigeria, and determining the possible 
factor(s) that accounted for such non-adherence with a 
view to identifying areas of  future intervention to im-
prove outcome.  
Methods
This study was carried out at the endocrinology out-
patient clinics of  University College Hospital (UCH), 
Ibadan and Obafemi Awolowo University Teaching 
Hospitals Complex (OAUTHC), Ile-Ife; both were lo-
cated in southwestern Nigeria. Each of  the two teaching 
hospitals has endocrinologist-managed diabetes clinic 
where different categories of  ambulatory and institu-
tionalized patients within and outside the region receive 
treatment. Ethical approval for the study was obtained 
from the joint University of  Ibadan/University College 
Hospital Institution Review Board.
A prospective cross-sectional interview guided by a pre-
tested structured questionnaire designed using the con-
cept of  RIM (Recognize, Identify, and Manage) model22 
was conducted among adult patients with type 2 diabe-
tes recruited from the out-patient endocrinology clinic 
of  the two hospitals between 15th November, 2010 and 
16th January, 2011. Patients who qualified for inclusion 
into the study were those who had been on antidiabe-
tes medications for more than three months prior to 
the time of  the study so as to ensure their familiariza-
tion with hypoglycemic medications. Eligible patients 
also had average of  fasting blood glucose (FBG) values 
for the two most recent consecutive measurements > 
6.11 mmol/L. This is to ensure that patients with FBG 
above the United Kingdom Prospective Diabetes Study 
(UKPDS)23 recommended blood glucose goals (FBG ≤ 
6.0 mmol/L) were enrolled. However, all type 1 diabetes 
patients, and type 2 diabetes patients who were uncon-
scious or who declined participation were excluded. 
The target sample size was calculated based on the as-
sumption of  5% margin of  error, and 95% confidence 
level with an estimated population of  340 patients for 
the eight weeks study period obtained from the average 
number of  ambulatory type 2 diabetes patients (40 to 
45 per week) who regularly attended the diabetes clinic 
of  the hospitals. Based on these assumptions, a target 
sample size of  approximately 185 was computed using 
a sample size calculator (www.surveysystem.com/sscal.
html)24. 
Patients were approached for participation while they 
were waiting to see the physician on every diabetes 
clinic days. Objectives of  the study were explained to 
patients individually, after which an informed written 
consent was obtained from individual patient to signi-
fy their willingness to participate in the study. Elderly 
patients were assisted by caregivers who accompanied 
them to the hospital, while clarifications were made for 
patients who did not understand English Language by 
the principal investigator. Translation and back-transla-
tion of  responses for patients were subsequently done 
to maintain response consistency. Only patients who 
gave voluntary informed written consent for partici-
pation were enrolled. Out of  185 patients approached 
for participation within the study period; a total of  176 
(95.1%) consented to participate from the two hospitals 
including 113 (64.2%) from UCH and 63 (35.8%) from 
OAUTHC. Participation was voluntary and patients 
were assured of  their anonymity and confidentiality of  
responses. 
The questionnaire used for the study was assessed for 
clarity and validity of  content by two consultant endo-
crinologists and by two pharmacists who are scholars 
in diabetes mellitus. A pre-test of  the sampling and 
recruitment procedures was done among fifteen ran-
domly selected, recently diagnosed patients with type 2 
diabetes chosen from the University College Hospital. 
Patients who were selected for the pre-test were solely 
considered for interaction in order to identify areas of  
possible challenge(s) that may be encountered during 
the recruitment phase of  the main study, especially with 
respect to the appropriate strategy for sampling, as well 
as ease of  comprehension of  the item-statement in the 
questionnaire. These patients do not qualify for inclu-
sion into the main study and were subsequently exclud-
ed from the final computation of  data. Based on feed-
back from the pre-test and validity assessment, some 
questions were rephrased to eliminate ambiguity, in 
particular some questions which were initially designed 
in closed-ended dichotomous “Yes/No” questions 
were reframed as open-ended questions with relevant 
prompts to guide patients and ensure clarification of  
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intentions.
The questionnaire was divided into two sections: sec-
tion A obtained information on socio-demographic 
data. Section B contained questions which obtained 
information on knowledge of  duration of  antidiabetes 
treatment plans, duration of  diagnosis, and question 
styles which were designed using the concept of  RIM 
model22 to assess non-adherence behavior of  patients. 
RIM model is a patient-centered questioning approach 
that provides a framework for recognizing non-adher-
ence problem, identifying the cause of  the problem as 
well as resolving or managing individual non-adherence 
deficits. The question styles in RIM model contained 
open-ended “Prime questions” e.g. “What were you told 
the medication is used for?, how were you told to take the medica-
tion”; and modified “Show and Tell” questions (MSTQ) 
e.g. “How do you take this medication?”. Prime questions 
and MSTQ were explored in order to recognize medica-
tion non-adherence problem(s) among patients. Ques-
tion styles in universal statements e.g. “Many patients have 
difficulty in adjusting their food styles to the prescribed diabetes 
diet, how are you coping with the dietary challenge?”, and re-
flective response e.g. “It sounds like some of  the biggest prob-
lems you have with taking your medications and other treatment 
recommendation as your doctor has prescribed are ________”, 
were also explored so as to further identify the possible 
factor(s) for non-adherence in individual patient. 
Baseline adherence to prescribed medications and diet 
were assessed using self-reported medication adher-
ence score (SRMAS) and self-reported dietary adher-
ence score (SRDAS) with numerical rating scale ranging 
from one (low commitment) to ten (total or complete 
commitment). A binary categorization of  SRMAS and 
SRDAS utilizing a cut-off  of  ≥ 8 for outstanding adher-
ence and < 8 for poor adherence were developed based 
on distribution of  the data and previous studies25,26. Pa-
tients’ opinions on the extent of  commitment to the 
recommended dietary restrictions were also evaluated 
in a likert scale format as “very comfortable” (assigned 
a score of  4), “comfortable” (3), “fairly comfortable” 
(2) and “uncomfortable” (1). 
The questionnaire which took about 20 minutes to 
complete were administered to patients by the principal 
investigator on every diabetes clinic days of  each hospi-
tal (Mondays for UCH; Thursdays for OAUTHC). 
Data were sorted, coded and entered into Predictive 
Analytics Software (PASW) for Windows (version 
17.0.). Descriptive statistics including frequency and 
percentage were used to summarize the data. Associa-
tion between categorical variables including socio-de-
mographic data, and adherence status in binary vari-
ables was evaluated using Chi-square or Fisher’s exact 
test as may be appropriate. Opinion on the extent of  
commitment to dietary restrictions between genders 
was evaluated using Mann-Whitney U test with p<0.05 
considered significant.
Results
The mean age was 60.2±10.2 years. One hundred and 
eight (61.4%) were females and 68 (38.6%) were males. 
Majority, (70; 39.8%) were traders, 37 (21.0%) were re-
tirees, 28 (15.9%) were civil servants, 23 (13.1%) were 
professionals, 10 (5.7%) were unemployed, and 8 (4.5%) 
were artisans. Fifty-four (30.7%) had no formal educa-
tion, 40 (22.7%) had primary education, 43 (24.4%) had 
secondary, and 39 (22.2%) had tertiary education. The 
mean duration of  diagnosis was 6.3±5.6 years. The mean 
self-reported medication adherence score (SRMAS) was 
7.3±1.7. Ninety-one (52.9%) gave a SRMAS of  ≥ 8 in-
dicating outstanding adherence, while 81 (47.1%) gave a 
SRMAS of  < 8 suggesting poor medication adherence. 
Association between socio-demographic characteristics 
and SRMAS in binary categories of  adherence versus 
non-adherence is shown in Table 1. 
Non-adherence components among patients included 
those due to medication (55; 32.9%), diet (9; 5.4%), 
medication plus diet (98; 58.7%), and combination of  
medication, diet and exercise (5; 3.0%). Patterns of  
medication non-adherence behavior among patients are 
shown in Table 2. 
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Table 1: Association between socio-demographic variables and self-reported medication adherence score (SRMAS) in binary 
categories
Variables Adherent (SRMAS ≥ 8)
                           N (%)
Non-adherent (SRMAS < 8) p –value
Age (year)
30-40 3 (50.0) 3 (50.0)
41-50 9 (33.3) 18 (66.7)
51-60 31 (58.5) 22 (41.5) 0.135**
61-70 35 (59.3) 24 (40.7)
Above 70 13 (48.1) 14 (51.9)
Sex
Male 38 (56.7) 29 (43.3)
Female 53 (50.5) 52 (49.5) 0.424*
Educational qualification
No formal education 27 (51.9) 25 (48.1)
Primary 18 (47.4) 20 (52.6)
Secondary 22 (51.2) 21 (48.8) 0.552*
Tertiary 24 (61.5) 15 (38.5)
Occupation
Traders 31 (45.6) 37 (54.4)
Civil servant 15 (53.6) 13 (46.4)
Artisans 4 (51.7) 3 (42.9)
Retiree 24 (66.7) 12 (33.3) 0.331**
Professionals 13 (56.5) 10 (43.5)
Unemployed 4 (40.0) 6 (60.0)
Duration of  diagnosis 
(year)
3 months - < 1 year 6 (60.0) 4 (40.0)
1-10 69 (52.7) 62 (47.3)
11-20 15 (60.0) 10 (40.0) 0.097**
Above 20 1 (16.7) 5 (83.3)
Level of  significance p < 0.05, SRMAS = Self-reported medication adherence score,  N= number, * Chi-square test, ** Fisher’s exact test
The factors identified as possible barriers to medication 
adherence among patients summarily include practical 
(145; 40.1%), knowledge (103; 28.5%), and attitudinal 
(114; 31.5%) barriers.  Out of  the patients (15; 8.5%) 
who manifested the trio of  knowledge, attitudinal and 
practical (KAP) barriers to medication adherence in 
combination, majority (40.0%) had no formal educa-
tion compared to a proportion of  20.0%, 26.7% and 
13.3% patients who had primary, secondary, and terti-
ary education respectively with no significant difference 
(p=0.18). Also, of  the patients who exhibited the triple 
combination of  KAP barriers to medication adherence, 
majority were traders (46.7%), followed by retirees 
(20.0%), civil servants and artisans constituted a pro-
portion of  13.3% each, while 6.7% were professionals 
(p=0.23). In addition, majority (80.0%) of  the patients 
with the trio of  KAP barriers to medication adherence 
had duration of  diagnosis within 1-10 years compared 
to a proportion of  20.0% who had duration of  diagno-
sis within 11-20 years (p=0.35).
Evaluation of  response to modified “Show and Tell” 
questions (MSTQ) indicated that 56 (32.9%) correct-
ly described medication name, and dosage regimen 
but were inaccurate with administration of  hypoglyc-
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emic medications with regard to meal time. Twenty-six 
(15.3%) accurately described current medications use 
with respect to medication name, dosage regimen, and 
medication administration with regard to meal time; 21 
(12.4%) correctly cited medication name but were in-
accurate with dosage regimen and intake with respect 
to meal time. Twenty (11.8%) patients got the medi-
cation name and dosage schedule correctly, but were 
inaccurate with medication dose and administration in 
accordance to meal time; 15 (8.8%) were completely in-
accurate with respect to medication name, dosage regi-
men, and medication administration in relation to meal 
time; while 32 (18.8%) were unable to give any infor-
mation on medication use. Of  the patients who accu-
rately described every aspects of  medication-taking as 
prescribed, 9 (34.6%) and 8 (30.8%) had secondary and 
tertiary education respectively, compared to 6 (23.1%) 
and 3 (11.5%) patients who had primary and no formal 
education respectively (p=0.07). Also, among patients 
who correctly described medication name and dosage 
regimen but inaccurate with medication administration 
in regard to meal time, 13 (23.2%) each had primary and 
no formal education compared to 11(19.6%) and 19 
(33.9%) patients who had secondary and tertiary educa-
Table 2: Pattern of  medication non-adherence behavior among patients and factor(s) identified as possible barrier(s) 
Medication non-adherence behavior and the identified barrier (n=362) Frequency Percent
A Practical barrier 145 40.1
Non-refill of  prescriptions  due to relatively high cost of  medication(s) 56 15.5
Confusion of  dosage regimen 20 5.5
Inappropriate storage of  insulin 19 5.2
Nature of  job incompatible with dosage regimen 16 4.4
Premature discontinuation of  medications due to side effects 15 4.1
Dose omission 9 2.5
Forgetfulness 4 1.1
Memory/cognitive impairment 3 0.8
Nonavailability/scarcity of  prescribed brand of  medication(s) 3 0.8
B Attitudinal barrier 114 31.5
Concomitant use of  herbal concoction with prescribed medication 28 7.7
Upward or downward self-adjustment of  medication dosage 25 6.9
Burden of  daily intake of  medication(s) 16 4.4
Inappropriate/irrational prescription refill 12 3.3
Not convinced of  the need for prescribed medications 11 3.0
Dislike for insulin injection 7 1.9
Self-medication with unprescribed over-the-counter  medicines 5 1.4
Inability to carry medication around or travel/ fear of  stigmatization 3 0.8
Belief  that medications need to be taken together for optimal outcome 3 0.8
Medication discontinuation because of  self-contentment 2 0.6
Visiting multiple clinics for consultation 2 0.6
C Knowledge barrier 103 28.5
 Medication use without regard to time of   meal 45 12.4
Lack of  understanding of  indication for specific medication prescribed 42 11.6
Purchase of  unauthorized/non-NAFDAC approved medications 6 1.7
Assumption that prescribed medications could only be refill during clinic appointment 5 1.4
Unaware of   the need for continue intake of  the prescribed hypoglycemic medications 3 0.8
Simultaneously taking two brands of  medication with same generic content 2 0.6
A, B, C subgroups = Identified barrier(s) to medication adherence; NAFDAC = National Agency for Food and Drugs, Administration and Control
tion respectively (p=0.07). In addition, of  the patients 
who were completely inaccurate with the description 
of  dosage regimen as prescribed, majority (6; 40.0%) 
had no formal education, 5 (33.3%) had primary educa-
tion, 4 (26.7%) had secondary education, while none of  
these patients had tertiary education (p=0.07). 
In addition, only 2 (1.2%) patients could correctly men-
tion the indication for each medicine in their regimen, 
as well as the general purpose for the prescribed medi-
Table 3: Pattern of  non-drug therapy recommended for patients
Non-drug therapy (n = 176) Frequency Percent (%)
Dietary restriction alone 83 47.2
Dietary restriction + Moderate exercise 77 43.8
Dietary restriction + Salt restriction 7 4.0
Dietary restriction+  Moderate exercise + Salt restriction 3 1.7
Dietary restriction+ Moderate exercise + Weight reduction 3 1.7
Dietary restriction +  Weight reduction 2 1.1
Dietary restriction + Exercise + Alcohol/smoking cessation 1 0.6
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cations. Eighteen (10.4%) neither had knowledge of  
the general purpose of  prescribed medications nor the 
indication for specific medicine in the regimen. More 
than three quarters (153; 88.4%) were not aware of  the 
indication for each of  the medications prescribed but 
were aware of  the purpose for which the medications 
were generally prescribed. 
Patterns of  non-drug therapy recommended for pa-
tients are shown in Table 3. 
Majority, (90; 94.7%) complained of  difficulty with di-
etary restrictions; 3 (3.2%) mentioned inconvenience 
of  exercise because of  work schedule or job demands; 
and 2 (2.1%) mentioned problem with salt restriction. 
The mean self-reported dietary adherence score (SR-
DAS) was 6.0±1.9. Thirty-five (29.9%) gave a SRDAS 
of  ≥ 8 indicating outstanding dietary adherence, while 
82 (70.1%) gave a SRDAS score of  < 8 suggesting poor 
dietary adherence. There was no significant association 
between patients’ dietary adherence status and socio-de-
mographic characteristics with respect to age (p=0.79), 
sex (p=0.06), educational qualification (p=0.60) and 
occupation (p=0.71), as well as duration of  diagnosis 
(p=0.65). Also, opinion on self-assessment to indicate 
extent of  commitment to dietary restrictions among 
patients showed that 55 (43.3%) found dietary restric-
tions uncomfortable; 30 (23.6%) fairly comfortable; 40 
(31.5%) comfortable, and 2 (1.6%) found adherence 
to dietary restrictions very comfortable. Males and fe-
males significantly differed in their opinions on extent 
of  commitment to dietary restrictions (Mann-Whitney 
U = 1434.5, p = 0.02). 
Barriers to optimal dietary adherence cited by patients 
Table 4:  Opinions on diabetes self-management practices among patients 
Response Frequency Percent (%)
Blood glucose assessment (n =180)
Only measured blood glucose level on the clinic appointment date 84 46.7
Through the experienced symptom(s) 55 30.6
Through self-monitoring of  blood glucose 24 13.3
Only  knew blood glucose level from what the doctor says in the clinic 14 7.8
Checked from the nearby clinic or chemist before the appointment date         3 1.7
Self-care measure to manage hyperglycemia (n =173)
Use of  antidiabetic medicines 56 32.3
Adjust diet 25 14.5
Go to hospital to see a physician 25 14.5
Do not know 67 38.7
Self-care measure to manage hypoglycemia (n = 145)
Take a cube of   table sugar or 15-30 centiliter of   non-alcoholic soft drink 55 37.9
Never been hypoglycemic 47 32.4
Do not know 32 22.1
Eat moderate quantity of  carbohydrate-containing food 9 6.2
Take medication(s) 2 1.4
Practice of  self-monitoring of  blood glucose [SMBG] (n = 176)
Yes 39 22.2
No 137 77.8
If   yes, frequency of  SMBG
Once/twice in a week
Once in a while
Regularly on a daily basis













From this study, there were overlaps of  intentional and 
unintentional non-adherence among the cohort which 
is consistent with previous studies that identified mul-
titude of  factors responsible for treatment non-adher-
ence among type 2 diabetes patients27,28. The combina-
tion of  medication and dietary non-adherence noted 
among a significant proportion of  patients might have 
contributed to inadequate glycemic control. Summar-
ily, unintentional reasons for non-adherence mostly 
due to knowledge and practical barriers were more fre-
quent than intentional non-adherence behaviors which 
were mostly attitudinal. This finding may probably be 
in contrast to a study which reported that intentional 
reasons for non-adherence are common than uninten-
tional non-adherence29, nonetheless, the finding further 
underscores the need to encourage the use of  patient-
centered questioning approach as entrenched in RIM 
model22 as a reasonable strategy in resolving non-adher-
ence problems in routine clinical practice.
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included inappropriate guidance or education on healthy 
eating habits for diabetes patients (62; 33.7%), inability 
to desist from favourite food (60; 32.6%), nonavailabil-
ity of  appropriate food varieties (39; 21.2%), urge to eat 
to satisfaction at meal time (12; 6.5%), financial con-
straints to buy varieties of  food (7; 3.8%), tendency to 
engage in eating late in the night (2; 1.1%), and 2 (1.1%) 
cited urge to eat outside or in the midst of  friends and 
relatives. Thirty-nine (22.2%) reported to engage in the 
practice of  self-monitoring of  blood glucose (SMBG), 
and more than two-third (157; 92.4%) did not keep 
record of  either the self-monitored or hospital-meas-
ured blood glucose results. Majority, (84; 46.7%) used 
to check their blood glucose status only on the appoint-
ment days. Details of  patients’ knowledge on diabetes 
self-management practices are shown in Table 4. 
The knowledge gaps of  patients with regard to indica-
tion for each of  the prescribed medications, and the 
inaccurate description of  prescribed dosage regimens 
among a significant proportion of  patients are partly 
in agreement with previous studies30,31 which reported 
that over a third of  patients could not identify the indi-
cation for many of  their medications. The questioning 
approach of  RIM model22 using a style of  inquiry rather 
than the more common “indirect” or “simple direct’’ 
methods32 to probe for non-adherence facilitates the 
recognition and identification of  a significant propor-
tion of  patients who were having intentional (primary) 
or unintentional non-adherence or combination of  
both. 
The discrepancies in medical prescription knowledge of  
patients may also be a possible justification to support 
findings of  Bonnie (1974)33 and Scherwitz et al (1985)34 
that healthcare provider asked few questions and gave 
few instructions and advice for patients on chronic 
medical regimen vis-a-vis duration to take medication, as 
well as purpose and benefit of  the medications. None-
theless, educational background of  patients may be an 
important determinant of  the knowledge gap in medi-
cal prescription; of  note in this study was the fact that 
patients with tertiary education constituted the largest 
proportion of  those who accurately described every as-
pects of  medication-taking as prescribed compared to 
the proportion that had either primary or no formal 
education. Thus, non-threatening and non-judgmental 
questioning styles in RIM model22 may be a useful ap-
proach for pharmacists especially, and other healthcare 
provider in general to quickly verify and assess patients’ 
understanding of  their regimen, and uncover barriers to 
treatment adherence. Any discrepancy unearthed should 
be resolved therein in a time–efficient manner35. 
The most common intentional non-adherence behavior 
among the cohort included concomitant use of  herbal 
remedies with prescribed allopathic medicines without 
disclosing the practice to their primary care physician. 
Even though some of  the herbal remedies contain ac-
tive ingredients with blood glucose lowering effect36, 
indiscriminate or irrational concomitant use of  herbal 
concoction and allopathic medicine may result in po-
tential or actual adverse consequences, and may also 
lead to therapeutic failure of  the allopathic medicine. 
Healthcare providers should therefore take cognizance 
of  this practice of  non-disclosure of  herbal medicine 
use among patients thereby ensuring the utilization of  
a non-threatening and non-accusatory probe to unveil 
this aspect of  intentional non-adherence behavior dur-
ing patient-provider interaction. 
Also, the practice of  upward or downward self-adjust-
ment of  medication dosages among patients, as well as 
engaging in irrational or inappropriate refill of  prescrip-
tion may partly be due to the relatively high cost of  
prescribed medications, unfounded fears and concerns 
about the side effects of  medication(s), and patients not 
being fully convinced of  the necessity for continued 
used of  the medications37,38. Patient-centered question-
ing approach may therefore be a reasonable strategy in 
resolving intentional and unintentional non-adherence 
behavior of  patients. Non-refill of  prescriptions due 
to relatively high cost of  medications remains the most 
important reason for medication non-adherence, and 
this is consistent with previous studies in Nigeria21,39,40 
where financial constraint was identified as the major 
hindrance to medication adherence among type 2 dia-
betes patients. 
In the present study, a relatively above average score for 
self-reported dietary adherence may perhaps buttress 
the report that indicated dietary lifestyle adjustments as 
one of  the most challenging aspect of  management for 
many diabetes patients41,42. It is noted that inappropri-
ate guidance on healthy eating or dietary habits was the 
major reason for suboptimal dietary adherence among 
patients. This finding may be in part consistent with 
studies which reported that patients might be deviating 
from dietary recommendations due to contradictory and 
confusing advice from a variety of  sources including 
healthcare professionals, media, and social contact43,44. 
The suboptimal commitment to dietary recommenda-
tions is a call for concern among diabetes primary care 
provider, and this possibly suggests the need to ensure 
provision of  consistent and unequivocal dietary infor-
mation for type 2 diabetes patients generally42,45. 
Although, frequent self-monitoring of  blood glucose 
(SMBG) is significantly associated with better glycemic 
control46,47, the low level of  SMBG practice among 
significant proportion of  patients has been reported 
in numerous studies48,49. It is noted in this study that 
almost one-half  of  patients got to know their blood 
glucose status during physician appointment only, while 
more than three quarters did not keep record of  either 
the hospital-measured or self-monitored blood glucose 
results. Regular monitoring and keeping a record of  
blood glucose results are essential aspects of  diabetes 
self-management efforts that need to be consistently 
emphasized and encouraged among diabetes patients 
at every patient-healthcare provider’s encounter. More 
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importantly, physicians can use SMBG results to adjust 
medication and develop a rational treatment plan for 
patients21.
Notwithstanding the useful information provided in 
this study, it is however limited by the fact that the self-
report tools used in assessing patients’ adherence are as-
sociated with some inherent problem(s) such as patients 
who may tend to over report good adherence or under 
report poor adherence. There may also be the likelihood 
of  memory bias among patients. Nonetheless, there is 
no foolproof  method for assessing adherence with the 
direct and indirect methods linked to methodological 
flaws3,16,50. Self-report measure using non-threatening 
and non-judgmental questions has been described as a 
reliable tool to assess adherence to treatment recom-
mendations among patients51,52 .
Conclusion
It could therefore be concluded that, there were arrays 
of  intentional and unintentional non-adherence behav-
ior among patients with poorly controlled type 2 dia-
betes in ambulatory tertiary care settings used for this 
study. This finding may perhaps be a justification to 
support the need for patient-centered questioning ap-
proach as a reasonable strategy in resolving treatment 
non-adherence problems in routine clinical practice. 
Also, the poor dietary adherence and self-management 
practice are possible indicators for diabetes primary 
care providers to always ensure active involvement of  
patients in diabetes treatment plans in order to con-
sistently guarantee improved treatment adherence, and 
subsequently optimal glycemic outcome. 
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